Biomarker Testing in Advanced Cancer Still Lags Behind Guideline Recommendations

(MedPage Today) — Only a third of patients with advanced cancer had molecular testing to help guide the use of targeted therapies, a review of 26,000 patients showed.
Overall, 35% of patients’ records had evidence of comprehensive genomic profiling…